Abstral Articles
News briefs from Genzyme, Sagent, Orchid and Kyowa Hakko
14 November 2012
Orexo licenses Abstral to Invida for in Asia Pacific: GlaxoSmithKline gets rights to bilastine in Spain and Poland
17 January 2011
US FDA finally approves ProStrakan opioid analgesic Abstral
10 January 2011
ProStrakan faces Abstral production shortage and FDA hold-up of Sancuso, as CEO resigns
8 September 2010
Painful wait for ProStrakan on Abstral’s US approval
18 August 2010
US FDA delays ProStrakan’s Abstral approval
3 June 2010
Showing 1-8 of 8 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
